How eczema may trigger asthma via immune cell activity

Child's hand gently touching an adult's neck in a moment of affection and closeness

A new study found that specialized immune cells called basophils trigger a chain reaction where eczema allergens sensitize the skin and later cause asthma in the lungs, explaining why these two allergic diseases often occur together.

  • Basophils are immune cells that damage the skin barrier and trigger allergen-specific antibodies, establishing conditions for respiratory disease
  • Both eczema and asthma share elevated IgE levels and type 2 immune responses, indicating a common allergic pathway
  • The findings explain the atopic march — the progression where allergic diseases evolve from eczema in childhood to asthma and other conditions

A study published in the European Journal of Allergy and Clinical Immunology has uncovered a key biological mechanism that may explain why people with eczema often develop asthma. In the paper, “Basophils in Skin-Mediated Sensitization Drive Subsequent Lung Inflammation in Airway-Challenged Mice,” researchers found that specialized immune cells known as basophils play a critical role in driving allergic responses that begin in the skin and later affect the lungs.

Atopic dermatitis (eczema) and asthma are among the most common allergic diseases worldwide, according to the study’s authors. Physicians have long observed that the two conditions frequently occur together, they said, but the biological connection between them has remained unclear. According to the study, both diseases are characterized by elevated levels of immunoglobulin E (IgE) and type 2 immune responses, suggesting a shared allergic pathway. 

Using mouse models designed to mimic eczema, investigators examined what happens when allergens enter through inflamed skin. The research demonstrated that basophils contribute to skin barrier damage, stimulate the production of allergen-specific IgE antibodies and promote sensitization that later leads to allergic lung inflammation.

One of the study’s most significant findings was that removing basophils during the skin-sensitization phase substantially reduced subsequent allergic reactions. Mice lacking basophils showed lower rates of IgE-mediated anaphylaxis and less inflammation in the lungs after allergen exposure. Researchers also observed reduced eosinophil accumulation and lower levels of inflammatory chemokines associated with asthma-related immune responses. 

Investigators said the findings suggest that basophils do more than contribute to allergic reactions; they establish the immune conditions that allow allergens encountered through the skin to trigger respiratory disease.

Researchers said they believe their results shed light on the broader concept of the “atopic march,” the progression in which allergic diseases evolve over time, often beginning with eczema in childhood and later developing into asthma or other allergic conditions.

Although the research was conducted in animal models and does not fully replicate the complexity of human eczema, the authors said the findings could guide future preventive therapies, including the use of the drug difamilast to one day reduce the risk of developing asthma and other allergic comorbidities.

More in Asthma
Page 1 of 30
Next Page